RxAll is an AI-hyperspectral platform for authenticating medicines. Their platform uses a proprietary molecular sensor device with a cloud-based IP-protected AI algorithm and database of spectral signatures of medicines to carry out non-destructive pill authentication. They work with pharma manufacturers and their partners to reduce branded drug counterfeiting and ensure that patients receive high quality authenticated medicines. Pharma manufacturers increase sales and patients have better access to high quality medicines. They are expanding their business in Africa- currently operational in Nigeria, Kenya and Singapore. Users will find RxAll’s technology unique as it aims to assure the quality of medicines delivered to patients in growth countries.
Read more on their website: https://www.rxall.net/